Biomarker assays have brought significant challenges to bioanalytical laboratories that historically have provided pharmacokinetic analytical services to the drug development industry.
EVERY PATIENT IS UNIQUE
EVERY PATIENT IS UNIQUE
Biomarker assays have brought significant challenges to bioanalytical laboratories that historically have provided pharmacokinetic analytical services to the drug development industry.
Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality.
© 2021 Biomarkers Healthcare Pvt. Ltd. All rights reserved